Approved in 1964 for the management of hypertension, propranolol is now used for a wide range of cardiovascular diseases, including ischemic heart disease, angina pectoris, arrhythmias, and myocardial infarction, as well as non cardiovascular conditions, including migraine, tremors and anxiety
The FDA approved Semaglutide for weight management in 2021 under the brand name Wegovy, following clinical trials that showed participants achieved an average weight loss of up to 15% of their body weight when combined with lifestyle changes
There are also strict labeling requirements for branded and generic products, whereas the requirements for compounded ones are much more lax
While this provides excellent measurement precision, it results in larger injection volumes